- Home
- UGRO vs AEON Comparison
UGRO vs AEON Comparison
Compare UGRO & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- AEON
- Stock Information
- Founded
- UGRO 2014
- AEON N/A
- Country
- UGRO United States
- AEON United States
- Employees
- UGRO N/A
- AEON N/A
- Industry
- UGRO Industrial Specialties
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- AEON Health Care
- Exchange
- UGRO Nasdaq
- AEON Nasdaq
- Market Cap
- UGRO 5.5M
- AEON 5.7M
- IPO Year
- UGRO N/A
- AEON N/A
- Fundamental
- Price
- UGRO $0.39
- AEON $0.82
- Analyst Decision
- UGRO Strong Buy
- AEON Strong Buy
- Analyst Count
- UGRO 1
- AEON 1
- Target Price
- UGRO $3.00
- AEON $360.00
- AVG Volume (30 Days)
- UGRO 117.3K
- AEON 1.9M
- Earning Date
- UGRO 06-17-2025
- AEON 05-14-2025
- Dividend Yield
- UGRO N/A
- AEON N/A
- EPS Growth
- UGRO N/A
- AEON N/A
- EPS
- UGRO N/A
- AEON 73.23
- Revenue
- UGRO $59,985,133.00
- AEON N/A
- Revenue This Year
- UGRO N/A
- AEON N/A
- Revenue Next Year
- UGRO $31.25
- AEON N/A
- P/E Ratio
- UGRO N/A
- AEON $0.01
- Revenue Growth
- UGRO N/A
- AEON N/A
- 52 Week Low
- UGRO $0.29
- AEON $0.38
- 52 Week High
- UGRO $1.92
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- UGRO 49.87
- AEON 67.31
- Support Level
- UGRO $0.29
- AEON $0.53
- Resistance Level
- UGRO $0.42
- AEON $0.85
- Average True Range (ATR)
- UGRO 0.03
- AEON 0.08
- MACD
- UGRO 0.01
- AEON 0.05
- Stochastic Oscillator
- UGRO 76.92
- AEON 92.78
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.